-transparent.png){kind=logo}
The effects of heparin administered during dialysis on serum lipids and lipoproteins were evaluated by comparing dialysis with heparin and dialysis without heparin. Gabexate mesilate (GM), a synthetic proteinase inhibitor, was used as an anticoagulant during dialysis without heparin. In dialysis with heparin, significant increases were observed in free fatty acids (FFA), high-density lipoprotein cholesterol (HDL-C), and plasma lipolytic activity (PLA). Triglyceride (TG) was decreased reciprocally and the lipoprotein electrophoretic pattern was markedly modified. In contrast, in dialysis without heparin, no significant changes were observed in all parameters of lipid metabolism. These data suggest that dialysis induced changes in lipids are mainly caused by heparin and that acetate and glucose in dialyzate make an almost negligible contribution to abnormal lipid patterns in patients on maintenance hemodialysis.
J Teraoka, and
N Matsui, and
S Nakagawa, and
J Takeuchi
January 1978,
Revista clinica espanola,
J Teraoka, and
N Matsui, and
S Nakagawa, and
J Takeuchi
January 1999,
Nephron,
J Teraoka, and
N Matsui, and
S Nakagawa, and
J Takeuchi
January 1990,
Urologiia i nefrologiia,
J Teraoka, and
N Matsui, and
S Nakagawa, and
J Takeuchi
December 1992,
Minerva medica,
J Teraoka, and
N Matsui, and
S Nakagawa, and
J Takeuchi
January 2024,
Seminars in nephrology,
J Teraoka, and
N Matsui, and
S Nakagawa, and
J Takeuchi
January 2013,
Hemodialysis international. International Symposium on Home Hemodialysis,
J Teraoka, and
N Matsui, and
S Nakagawa, and
J Takeuchi
November 1989,
Therapeutic drug monitoring,
J Teraoka, and
N Matsui, and
S Nakagawa, and
J Takeuchi
January 1985,
The Journal of laboratory and clinical medicine,
J Teraoka, and
N Matsui, and
S Nakagawa, and
J Takeuchi
April 1984,
Clinical nephrology,
J Teraoka, and
N Matsui, and
S Nakagawa, and
J Takeuchi
July 1985,
Clinical nephrology,
